Moran, Lisa J.

Recommendations from the international evidence‐based guideline for the assessment and management of polycystic ovary syndrome

Teede, H. J., Misso, M. L., Costello, M. F., Dokras, A., Laven, J., Moran, L., Piltonen, T., Norman, R. J., & the International PCOS Network (2018) · Clinical Endocrinology

Ovarian function and disordersClinical practice guidelines implementation

Cited by 1,823

Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome

Teede, H. J., Misso, M. L., Costello, M. F., Dokras, A., Laven, J., Moran, L., Piltonen, T., Norman, R. J., International PCOS Network, Andersen, M., et al. (2018) · Human Reproduction

Ovarian function and disordersClinical practice guidelines implementation

Cited by 1,593

Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan

Teede, H., Deeks, A., & Moran, L. (2010) · BMC Medicine

Ovarian function and disordersDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 1,565

Recommendations from the International Evidence-Based Guideline for the Assessment and Management of Polycystic Ovary Syndrome

Teede, H. J., Misso, M. L., Costello, M. F., Dokras, A., Laven, J., Moran, L., Piltonen, T., Norman, R. J., Andersen, M., Azziz, R., et al. (2018) · Fertility and Sterility

Ovarian function and disordersClinical practice guidelines implementation

Cited by 1,325

Impaired Glucose Tolerance, Type 2 Diabetes and Metabolic Syndrome in Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis

Moran, L. J., Misso, M. L., Wild, R. A., & Norman, R. J. (2010) · Human Reproduction Update

Ovarian function and disordersDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 1,108

Recommendations From the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome

Teede, H. J., Tay, C. T., Laven, J. J. E., Dokras, A., Moran, L. J., Piltonen, T. T., Costello, M. F., Boivin, J., Redman, L. M., Boyle, J. A., et al. (2023) · The Journal of Clinical Endocrinology & Metabolism

Ovarian function and disordersClinical practice guidelines implementation

Cited by 946

Overweight, obesity and central obesity in women with polycystic ovary syndrome: a systematic review and meta-analysis

Lim, S. S., Davies, M. J., Norman, R. J., & Moran, L. J. (2012) · Human Reproduction Update

Ovarian function and disordersDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 939

Polycystic ovary syndrome

Joham, A. E., Norman, R. J., Stener-Victorin, E., Legro, R. S., Franks, S., Moran, L. J., Boyle, J., & Teede, H. J. (2022) · The Lancet Diabetes & Endocrinology

Ovarian function and disordersEndometriosis Research and Treatment

Cited by 838

Effects of energy-restricted high-protein, low-fat compared with standard-protein, low-fat diets: a meta-analysis of randomized controlled trials

Wycherley, T. P., Moran, L. J., Clifton, P. M., Noakes, M., & Brinkworth, G. D. (2012) · The American Journal of Clinical Nutrition

Diet and metabolism studiesDietary Effects on Health

Cited by 606

The effect of obesity on polycystic ovary syndrome: a systematic review and meta‐analysis

Lim, S. S., Norman, R. J., Davies, M. J., & Moran, L. J. (2013) · Obesity Reviews

Ovarian function and disordersDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 539

Dietary Composition in Restoring Reproductive and Metabolic Physiology in Overweight Women with Polycystic Ovary Syndrome

Moran, L. J., Noakes, M., Clifton, P. M., Tomlinson, L., & Norman, R. J. (2003) · The Journal of Clinical Endocrinology & Metabolism

Ovarian function and disordersDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 530

Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome

Teede, H. J., Tay, C. T., Laven, J. J. E., Dokras, A., Moran, L. J., Piltonen, T. T., Costello, M. F., Boivin, J., Redman, L. M., Boyle, J. A., et al. (2023) · European Journal of Endocrinology

Ovarian function and disordersClinical practice guidelines implementation

Cited by 525

Treatment of obesity in polycystic ovary syndrome: A position statement of the Androgen Excess and Polycystic Ovary Syndrome Society

Moran, L. J., Pasquali, R., Teede, H. J., Hoeger, K. M., & Norman, R. J. (2009) · Fertility and Sterility

Ovarian function and disordersDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 444

Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome

Teede, H. J., Tay, C. T., Laven, J., Dokras, A., Moran, L. J., Piltonen, T. T., Costello, M. F., Boivin, J., M. Redman, L., A. Boyle, J., et al. (2023) · Fertility and Sterility

Ovarian function and disordersClinical practice guidelines implementation

Cited by 417

Ethnicity, Obesity and the Prevalence of Impaired Glucose Tolerance and Type 2 Diabetes in PCOS: A Systematic Review and Meta-Regression

Kakoly, N. S., Khomami, M. B., Joham, A. E., Cooray, S. D., Misso, M. L., Norman, R. J., Harrison, C. L., Ranasinha, S., Teede, H. J., & Moran, L. J. (2018) · Human Reproduction Update

Ovarian function and disordersDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 384

Assessment and management of polycystic ovary syndrome: Summary of an evidence-based guideline

Teede, H. J., Misso, M. L., Deeks, A. A., Moran, L. J., Stuckey, B. G. A., Wong, J. L. A., Norman, R. J., Costello, M. F., & Groups, O. B. O. T. G. D. (2011) · Medical Journal of Australia

Ovarian function and disordersGenetic and Kidney Cyst Diseases

Cited by 379

Metabolic features of the reproductive phenotypes of polycystic ovary syndrome

Moran, L., & Teede, H. (2009) · Human Reproduction Update

Ovarian function and disordersDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 362

Longitudinal weight gain in women identified With polycystic ovary syndrome: Results of an observational study in young women

Teede, H. J., Joham, A. E., Paul, E., Moran, L. J., Loxton, D., Jolley, D., & Lombard, C. (2013) · Obesity

Ovarian function and disordersDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 351

Metformin and lifestyle modification in polycystic ovary syndrome: systematic review and meta-analysis

Naderpoor, N., Shorakae, S., de Courten, B., Misso, M. L., Moran, L. J., & Teede, H. J. (2015) · Human Reproduction Update

Ovarian function and disordersDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 334

Association of Antenatal Diet and Physical Activity–Based Interventions With Gestational Weight Gain and Pregnancy Outcomes: A Systematic Review and Meta-analysis

Teede, H. J., Bailey, C., Moran, L. J., Bahri Khomami, M., Enticott, J., Ranasinha, S., Rogozińska, E., Skouteris, H., Boyle, J. A., Thangaratinam, S., et al. (2022) · JAMA Internal Medicine

Gestational Diabetes Research and ManagementMaternal and Neonatal Healthcare

Cited by 329

The role of lifestyle modification in polycystic ovary syndrome

Norman, R. J., Davies, M. J., Lord, J., & Moran, L. J. (2002) · Trends in Endocrinology & Metabolism

Ovarian function and disordersDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 326

Metabolic syndrome in polycystic ovary syndrome: a systematic review, meta‐analysis and meta‐regression

Lim, S. S., Kakoly, N. S., Tan, J. W. J., Fitzgerald, G., Bahri Khomami, M., Joham, A. E., Cooray, S. D., Misso, M. L., Norman, R. J., Harrison, C. L., et al. (2019) · Obesity Reviews

Ovarian function and disordersDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 316

Lifestyle changes in women with polycystic ovary syndrome

Moran, L. J., Hutchison, S. K., Norman, R. J., & Teede, H. J. (2011) · Cochrane Database of Systematic Reviews

Ovarian function and disordersDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 292

Exercise therapy in polycystic ovary syndrome: a systematic review

Harrison, C. L., Lombard, C. B., Moran, L. J., & Teede, H. J. (2011) · Human Reproduction Update

Ovarian function and disordersDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 267